REFERENCE FILE
Semaglutide
Read the record, then work through the questions.
Reference details
Status as of
- Regulatory category
- Approved product
- Evidence category
- Randomized evidence
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limitations
- Check other products separately.
- Safety
- Severe or persistent gastrointestinal symptoms: contact a clinician.
- Formulation and route
- This entry covers subcutaneous Wegovy injection.
- Approval scope
- Wegovy injection: weight management in eligible adults.
A SECOND LOOK
A question to carry into the reading
For this semaglutide profile, choose one statement and name the exact result it concerns before opening its citation. Then look for that same result in the source: what was assessed, over what period, and against which starting point? If the source answers a narrower question, keep that narrower wording in your notes. A phrase such as “works well” leaves the result unspecified. Replace it with a question you could check against the cited passage. This exercise gives you a clear boundary between the claim you found, the evidence you located, and the question that remains unanswered.
Questions to keep beside the page
- Which exact result would the cited source need to measure to support this statement?
- Does the source address the same period and starting point as the profile statement?
- How could I rewrite my question so its answer would be checkable?
Sources for this file
- WEGOVYNLM · Checked
- Wegovy approvalFDA · Checked
FROM THE REFERENCE DESK